-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRAX-222 in Epileptic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRAX-222 in Epileptic Encephalopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRAX-222 in Epileptic Encephalopathy Drug Details: RC-222 is under development for the...